Biodexa PharmaceuticalsBDRX
About: Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.
Employees: 16
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
0% more ownership
Funds ownership: 0% [Q2] → 0.01% (+0%) [Q3]
36% less capital invested
Capital invested by funds: $136K [Q2] → $87.3K (-$48.3K) [Q3]
46% less funds holding
Funds holding: 13 [Q2] → 7 (-6) [Q3]
86% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 7
Research analyst outlook
We haven’t received any recent analyst ratings for BDRX.
Financial journalist opinion
Based on 6 articles about BDRX published over the past 30 days